Canine Protein-Losing Enteropathy: Workup and Diet

Bottom line

Protein-losing enteropathy is a syndrome that requires investigation of the cause of enteric protein loss, not an automatic diagnosis of inflammatory bowel disease. Exclude important renal and hepatic explanations for hypoalbuminemia. [1] Nutrition is central, but biopsy timing must reflect severity and stability rather than an obligatory sequence of prolonged diet trials. [2]

Localizing the low albumin

Evaluate the entire problem list before assigning an intestinal origin. Urinary protein assessment and hepatic functional evaluation help distinguish protein-losing nephropathy or impaired hepatic production from gastrointestinal loss. Imaging appearances such as mucosal striations are suggestive rather than specific. [1]

Record body and muscle condition, intake, weight trajectory, edema or effusion, and the albumin trend. The 2026 ACVIM statement includes nutritional assessment and disease-severity grading in the diagnostic evaluation of chronic inflammatory enteropathy. [2] A changing number without a concurrent clinical and dietary record is difficult to interpret.

Hypoadrenocorticism can mimic the syndrome. [1] Use the canine hypoadrenocorticism testing reference when the endocrine differential is relevant, preserving the distinction between an exclusion screen and confirmation.

Nutrition as active treatment

A prospective observational study found that some dogs with presumptive PLE and ultrasound evidence of lymphangiectasia achieved remission with low-fat diet alone; others required added prednisone or failed treatment. [3] This supports a monitored nutritional intervention, not a guarantee of diet-only response or histologic confirmation from ultrasound.

Choose an appropriate complete nutritional plan and document what is actually consumed. Review treats, scavenging, supplements, prior diets, palatability, and caloric intake before calling a trial unsuccessful. Where a formulated diet cannot meet the patient's needs, involve nutritional support rather than improvising a long-term unbalanced ration.

Diet deserves reassessment even after apparent steroid resistance. In a small prospective study, dietary alteration as the sole change in the existing treatment plan was followed by remission in most enrolled dogs. [4] That design cannot establish that diet alone replaces all other therapy, but it cautions against assuming that additional immunosuppression is the only next step.

Biopsy timing and diagnostic yield

The 2026 consensus individualizes endoscopy according to history, severity, and laboratory findings, including marked hypoalbuminemia. Severe illness or inability to perform a dietary trial may justify earlier investigation; a stable patient with hypoalbuminemia may undergo biopsy alongside dietary treatment. [2]

Discuss whether the patient can tolerate anesthesia and preparation, which segments need sampling, and whether imaging identifies a lesion beyond endoscopic reach. The same consensus notes that surgical samples are occasionally needed when endoscopy is inconclusive or lesions are inaccessible. [2]

Set the diagnostic question before collecting tissue: inflammatory disease, lymphatic pathology, infection, and neoplasia do not imply the same subsequent treatment. Preserve the imaging, sampling sites, and treatment history for the pathologist.

Complications and treatment escalation

PLE is associated with thrombotic risk. [1] Assess that risk and the patient's bleeding or procedural constraints explicitly with the treating team; this page does not provide a universal antithrombotic regimen or albumin threshold.

Empirical antibiotics are not recommended for suspected chronic inflammatory enteropathy in the 2026 ACVIM statement. [2] The metronidazole evidence reference addresses the drug's defined indications and harms. Neither diarrhea nor an initial nonspecific response establishes an infection requiring repeated courses.

Reassessment that can change the plan

Track clinical status, intake, body condition, albumin, treatment tolerance, and complications together. Specify which change prompts admission, earlier biopsy, nutritional assistance, or specialist review. Revisit the working diagnosis when response diverges from expectations rather than escalating medication from the albumin value alone.

Communicate whether PLE is presumptive, whether an underlying disease has been demonstrated, and what the nutritional trial has actually established. Keep maintenance of remission and investigation of relapse within the follow-up plan.

Frequently Asked Questions

Does hypoalbuminemia alone diagnose PLE?

No. Renal protein loss and hepatic failure are important alternative explanations that require evaluation. [1]

Are mucosal striations diagnostic of lymphangiectasia?

No. Ultrasound findings can support suspicion but are not specific enough to establish the cause of PLE. [1]

Can some dogs improve with low-fat diet alone?

Yes. A prospective observational study documented diet-only remission in some dogs with presumptive PLE and ultrasound evidence of lymphangiectasia. [3]

Does steroid resistance mean dietary treatment cannot help?

No. A small prospective study found benefit after dietary alteration as the sole change to an existing treatment plan. [4] It did not establish withdrawal of all other therapy.

Must biopsy wait until every dietary trial is complete?

No. The consensus individualizes timing, and marked hypoalbuminemia, severe illness, or inability to undertake a trial can change the diagnostic sequence. [2]

Are empirical antibiotics a routine PLE treatment step?

No. The 2026 statement recommends against empirical antimicrobials in chronic inflammatory enteropathy suspects. [2]

Why discuss thrombosis during procedural planning?

PLE is associated with thrombotic risk, which is relevant to anesthesia and intervention planning as well as overall care. [1]